+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
IPCALAB

Ipca Laboratories Share Price

 
New 52W High in past week

 

Ipca Laboratories live price: ₹1,760.50. It opened at ₹1,790 vs previous close ₹1,799; intraday high/low: ₹1,790/₹1,754. The 50 & 200 DMA stand at ₹1,682.20/₹1,538.90.

Ipca Laboratories Performance

  • Today's Low
  • ₹1,754
  • Today's High
  • ₹1,790
  • 52 Week Low
  • ₹1,252
  • 52 Week High
  • ₹1,945
  • Open Price₹1,790
  • Previous Close₹1,799
  • Volume29,615
  • 50 DMA₹1,682.20
  • 100 DMA₹1,609.30
  • 200 DMA₹1,538.90

Ipca Laboratories Chart

Investment Returns

  • Over 1 Month + 11.02%
  • Over 3 Month + 19.23%
  • Over 6 Month + 18.88%
  • Over 1 Year + 20.03%

Smart Investing Starts Here Start SIP with Ipca Laboratories for Steady Growth!

Invest Now

Ipca Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 39.1
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 44,665
  • P/B Ratio
  • 5.5
  • Average True Range
  • 59.5
  • EPS
  • 45
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 63.9
  • RSI
  • 58.26
  • MFI
  • 71.51

Latest Stock News Updates

Ipca Laboratories Ltd - 524494 - Intimation Of Web Link To Non-Email Cases

Intimation of web link to non-email cases

Ipca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Copy of Newspaper Publication

Ipca Laboratories Ltd - 524494 - 76Th Annual General Meeting Of Ipca Laboratories Limited To Be Held On Thursday, 13Th August, 2026

76th Annual General Meeting of Ipca Laboratories Limited to be held on Thursday, 13th August, 2026

Ipca Laboratories Financials

Ipca Laboratories Technicals

EMA & SMA

Current Price
₹1,760.50
-38.5 (-2.14%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹1,773.40
  • 50 Day
  • ₹1,682.20
  • 100 Day
  • ₹1,609.30
  • 200 Day
  • ₹1,538.90

Resistance and Support

1768.2 Pivot Speed
  • R3 1,894.00
  • R2 1,869.50
  • R1 1,834.20
  • S1 1,774.40
  • S2 1,749.90
  • S3 1,714.60

Ipca Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results & Dividend
2026-02-13 Quarterly Results
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results
2025-05-29 Audited Results & Final Dividend
Date Purpose Remarks
2026-08-07 FINAL Rs.6.00 per share(600%)Dividend
2025-08-05 FINAL Rs.2.00 per share(200%)Final Dividend
2024-11-25 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2023-11-22 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2022-11-23 INTERIM Rs.4.00 per share(400%)Interim Dividend
View Ipca Laboratories Dividend History Arrow
Date Purpose Remarks
2022-01-11 Split Stock split from Rs. 2/- to Re. 1/-.
2010-03-23 Split

Ipca Laboratories Shareholding Pattern

44.72%
31.15%
10.72%
7.19%
6.21%

About Ipca Laboratories

Ipca Laboratories is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical Ingredients (APIs). The Company is an integrated pharmaceutical company manufacturing and marketing. View More
  • NSE Symbol
  • IPCALAB
  • BSE Symbol
  • 524494
  • Executive Director.(Professional.),Managing Director,Chief Financial Officer,Non Promoter
  • A K Jain
  • ISIN
  • INE571A01038

Similar Stocks to Ipca Laboratories

Ipca Laboratories FAQs

Ipca Laboratories share price is ₹1,760 As on 22 July, 2026 | 09:36

The Market Cap of Ipca Laboratories is ₹44664.6 Cr As on 22 July, 2026 | 09:36

The P/E ratio of Ipca Laboratories is 39.1 As on 22 July, 2026 | 09:36

The PB ratio of Ipca Laboratories is 5.5 As on 22 July, 2026 | 09:36

The 52 week High & Low of Ipca Laboratories is ₹1944.9/₹1251.6 respectively As on 22 July, 2026 | 09:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23